High plasma level of plasmin-α2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer
- 15 January 1996
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 244 (1), 69-81
- https://doi.org/10.1016/0009-8981(95)06196-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Fibrin and CancerThrombosis and Haemostasis, 1993
- Evaluating Prethrombotic State In Lung Cancer Using Molecular MarkersChest, 1993
- Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancerCancer, 1992
- Cancer Cell Procoagulants and Their Role in Malignant DiseaseSeminars in Thrombosis and Hemostasis, 1992
- Prognostic significance of blood coagulation tests in carcinoma of the lung and colonBlood Coagulation & Fibrinolysis, 1992
- Fibrinolysis and CancerSeminars in Thrombosis and Hemostasis, 1990
- Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitorBlood, 1987
- A New International Staging System for Lung CancerChest, 1986
- Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75JAMA, 1981
- TROUSSEAUʼS SYNDROME AND OTHER MANIFESTATIONS OF CHRONIC DISSEMINATED COAGULOPATHY IN PATIENTS WITH NEOPLASMSMedicine, 1977